Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
(NASDAQ: FULC) Delayed: 3.44 --0 (-0%)
Previous Close $3.44    52 Week High
Open $3.44    52 Week Low
Day High $3.44    P/E N/A 
Day Low $3.44    EPS
Volume 5,224